Table 2 Comparisons across patients assessed in 2019 versus patients assessed in 2020
From: The impact of COVID-19 on adolescents with eating disorders: a cohort study
n | 2019 Patients | n | 2020 Patients | t-test (p-value) | Cohen’s d | |
|---|---|---|---|---|---|---|
zBMI | 43 | −0.97 (1.30) | 48 | −1.09 (1.47) | 0.42 (ns) | 0.08 |
%TGW | 33 | 82.64 (8.47) | 43 | 77.25 (9.21) | 2.62 (.011) | 0.61 |
Weight loss (kg) | 29 | 13.33 (10.21) | 39 | 13.93 (7.83) | 0.27 (ns) | 0.07 |
Symptom length (weeks) | 37 | 44.60 (36.76) | 40 | 38.90 (34.05) | 0.71 (ns) | 0.16 |
Rate (kg lost per week) | 29 | 0.46 (0.33) | 39 | 0.63 (0.54) | 1.48 (ns) | 0.36 |
RCADS (t-scores) | ||||||
Depression | 38 | 66.29 (19.05) | 24 | 70.38 (15.76) | −0.88 (ns) | 0.23 |
Generalized Anxiety | 38 | 51.52 (15.34) | 24 | 56.20 (14.81) | −1.18 (ns) | 0.31 |
Obsessive/Compulsive | 38 | 55.24 (17.41) | 24 | 55.69 (13.86) | −0.11 (ns) | 0.03 |
Panic | 38 | 66.16 (22.78) | 24 | 64.18 (22.40) | 0.34 (ns) | 0.09 |
Separation Anxiety | 38 | 61.72 (20.88) | 24 | 63.24 (16.07) | −0.30 (ns) | 0.08 |
Social Phobia | 38 | 57.63 (14.50) | 24 | 62.23 (15.31) | −1.19 (ns) | 0.31 |
Total Anxiety | 38 | 60.69 (19.91) | 24 | 63.21 (16.52) | −0.52 (ns) | 0.14 |
Clinical Impairment from ED symptoms | 38 | 24.02 (15.88) | 24 | 30.63 (13.69) | −1.68 (.098) | 0.44 |
Emotion Dysregulation | 38 | 111.67 (30.78) | 24 | 107.10 (29.93) | 0.58 (ns) | 0.15 |
EDEQ-A | ||||||
Restraint | 30 | 2.72 (2.12) | 13 | 4.00 (1.78) | −1.90 (.065) | 0.63 |
Eating Concerns | 30 | 2.67 (1.96) | 13 | 3.37 (1.08) | −1.48 (ns) | 0.40 |
Shape Concerns | 30 | 3.57 (2.34) | 13 | 4.41 (1.86) | −1.14 (ns) | 0.38 |
Weight Concerns | 30 | 3.09 (2.19) | 13 | 4.14 (1.83) | −1.52 (ns) | 0.50 |
Total Score | 30 | 3.01 (2.05) | 13 | 3.98 (1.47) | −1.53 (ns) | 0.51 |
chEAT | 5 | 23.80 (17.50) | 11 | 38.29 (17.91) | −1.51 (ns) | 0.81 |